Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma group-Reference-Cited by-同舟云学术

Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma group

Published:1987-10 Issue:10 Volume:23 Page:1477-1483
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

Mouridsen H.T.,Bastholt L.,Somers R.,Santoro A.,Bramwell V.,Mulder J.H.,Van Oosterom A.T.,Buesa J.,Pinedo H.M.,Thomas D.,Sylvester R.

Publisher

Elsevier BV

Subject

Oncology

Reference13 articles.

1. Verweij J, van Oosterom AT, Pinedo HM. Melanomas, soft tissue and bone sarcomas. Eur J Cancer Clin Oncol In press.

2. The treatment of soft tissue sarcoma with focus on chemotherapy;Pinedo;Radiother Oncol,1986

3. Cyclophosphamide, vincristine, adriamycin and DTIC (CYVADIC) combination chemotherapy for treatment of advanced sarcomas;Yap;Cancer Treat Rep,1980

4. A 5-year experience with cyclophosphamide, vincristine, adriamycin and DTIC (CYVADIC) chemotherapy in 169 adults with advanced soft tissue sarcomas;Yap,1981

5. CYVADIC in advanced soft tissue sarcomas: a randomized study comparing two schedules;Pinedo;Cancer,1984

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas;Cancers;2023-10-18

2. Chemotherapeutic drugs for soft tissue sarcomas: a review;Frontiers in Pharmacology;2023-08-11

3. REAL-LIFE DATA OF PAZOPANIB USAGE IN SOFT TISSUE SARCOMA;Turkish Journal of Clinics and Laboratory;2023-06-30

4. Tislelizumab immunotherapy combined with chemotherapy in the treatment of a patient with primary anterior mediastinal undifferentiated pleomorphic sarcoma with high PD-L1 expression: A case report and literature review;Frontiers in Oncology;2023-04-05

5. A League of Its Own? Established and Emerging Therapies in Undifferentiated Pleomorphic Sarcoma;Current Treatment Options in Oncology;2023-02-02